QNCX (QNCX) Stock Price & Analysis
QNCX (QNCX) fell 5.81% to USD 29.5 as of September 9, 2026 at 09:45 UTC, according to Nexqual real-time market data.
QNCX last closed at USD 29.5; the session ranged USD 29.01–31.88 on volume of 12,692 shares. Market capitalization is —, with a 52-week range of USD 15.1–910 (NMS). Source: Nexqual, September 9, 2026 at 09:45 UTC.
Key Statistics (as of September 9, 2026 at 09:45 UTC)
| Price | USD 29.5 |
|---|---|
| Change | ▼ 5.81% (down) |
| Previous Close | USD 29.5 |
| Open | USD 29.5 |
| Day Range | USD 29.01 – 31.88 |
| 52-Week Range | USD 15.1 – 910 |
| Volume | 12,692 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (QNCX)
Nexqual's technical model rates QNCX "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of September 9, 2026 at 09:45 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.6 (neutral) |
| vs SMA50 | Above (USD 25.36) |
| MACD | 1.34 (positive) |
From QNCX's Latest SEC 10-K Filing (filed 2026-04-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MGRX | Mangoceuticals, Inc. | USD 0.41 | ▲ 5.38% |
| AIXI | XIAO-I Corporation | USD 3.26 | ▲ 573.55% |
| VRAX | Virax Biolabs Group Limited | USD 2.63 | ▲ 2.73% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.25 | ▲ 1.63% |
| RENX | RenX Enterprises Corp. | USD 1.79 | ▼ 16.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 09:45 UTC. This page is informational and not investment advice.